SOCIETAL CDMO INC: Statement of changes in beneficial ownership of securities
Press release · 4d ago
SOCIETAL CDMO INC: Current report
Press release · 05/27 00:00
Why Inovio Pharmaceuticals Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Benzinga · 05/24 12:04
BRIEF-Societal Cdmo Enters Agreement With Atossa Therapeutics To Provide Clinical Trial Services (CTS)
Reuters · 05/23 11:35
Societal CDMO (SCTL) Receives a Buy from Stephens
TipRanks · 05/12 16:26
Stephens & Co. Reiterates Overweight on Societal CDMO, Maintains $2.5 Price Target
Benzinga · 05/12 13:39
Laughing Water Capital - Lifecore Biomedical: Case Of A Stock With Little Downside Even Through Bankruptcy
Seeking Alpha · 05/12 03:15
Societal CDMO (SCTL) Receives a Buy from RBC Capital
TipRanks · 05/11 16:26
RBC Capital Reiterates Outperform on Societal CDMO, Maintains $2 Price Target
Benzinga · 05/11 14:33
Analysts Offer Insights on Healthcare Companies: Societal CDMO (SCTL), Phathom Pharmaceuticals (PHAT) and DarioHealth (DRIO)
TipRanks · 05/11 13:02
BRIEF-Societal Cdmo Reports Qtrly Loss Per Share $0.06
Reuters · 05/10 21:19
Earnings Scheduled For May 10, 2023
Benzinga · 05/10 13:12
Webull provides a variety of real-time SCTL stock news. You can receive the latest news about SOCIETAL CDMO INC through multiple platforms. This information may help you make smarter investment decisions.
About SCTL
Societal CDMO, Inc. is a bi-coastal contract development and manufacturing organization (CDMO). The Company is engaged in spanning pre-investigational new drug development to commercial manufacturing and packaging for a range of therapeutic dosage forms with a primary focus on the area of small molecules. It is involved in CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. The Company’s products include Ritalin LA, Focalin XR, Verelan PM, Verelan SR, Verapamil PM, Verapamil SR, Donnatal liquids and tablets and Scot-Tussin cough and cold liquids. Its manufacturing and development capabilities include product development from formulation through clinical trial and commercial manufacturing, and specialized capabilities for solid oral dosage forms and facilities to handle highly potent compounds and controlled substances.